Fig. 1From: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone graftsDistribution of treatment location according to the bone substitute; all cases in each group (allogeneic cancellous bone [ACB] or synthetic bone substitute [SBS]) amount to 100Â %. Exact numbers are stated in the figureBack to article page